The invention relates to a method for efficiently establishing a stably transfected
cell strain for knocking down and overexpressing a dyrk1b
gene. Comprising the following steps: designing a specific
RNA (Ribonucleic Acid) sequence to knock down a dyrk1b
gene, constructing
a DNA (
Deoxyribose Nucleic Acid) sequence for highly expressing dyrk1b, and carrying out
virus packaging and predetermined
cell infection by utilizing a three-generation
lentivirus system. A positive
clone cell strain is obtained through
Puromycin screening, OVCAR3 and 293T cells are infected by adopting a specific
plasmid proportion, and knock-down and overexpression efficiency is verified. According to the method, the function of the dyrk1b
gene is evaluated by observing the morphological change of OVCAR3 and COV362 cells, such as
cell body elongation and antenna growth. The innovation point of the invention is that an efficient
virus packaging
system and precise
gene expression regulation and control ensure the stability of the
cell strain and the reliability of the experiment. In addition, the invention also relates to application of the stably transfected cell strains in comprehensive treatment of
ovarian cancer magnetic hyperthermia,
small molecule inhibitor and
chemotherapy, and provides a new research tool and strategy for
cancer treatment.